https://www.globenewswire.com/news-release/2025/10/16/3168328/0/en/atai-life-sciences-and-beckley-psytech-announce-u-s-fda-breakthrough-therapy-designation-granted-to-bpl-003-underscoring-its-potential-in-treatment-resistant-depression.html
atai Life Sciences and Beckley Psytech Announce U.S. FDA
Breakthrough Therapy designation recognizes the potential of BPL-003 to deliver substantial improvement over existing therapies for patients with...
atai life sciencesbeckley psytechannouncefda
https://investingnews.com/stocks/nasdaq-atai-us/atai-life-sciences-n-v/
ATAI Life Sciences Stock Price, News, Quote & History | INN
May 1, 2026 - ATAI Life Sciences NV is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. Its product candidates...
atai life sciencesstock pricequote historynewsinn
https://www.financialcontent.com/article/gnwcq-2022-11-10-atai-life-sciences-reports-third-quarter-2022-financial-results-and-business-update
atai Life Sciences Reports Third Quarter 2022 Financial Results and Business Update |...
Video interview with Management to be posted today at 8:30 a.m. EST
atai life sciencesthird quarter
https://www.financialcontent.com/article/gnwcq-2025-5-14-atai-life-sciences-reports-first-quarter-2025-financial-results-and-recent-corporate-updates
atai Life Sciences Reports First Quarter 2025 Financial Results and Recent Corporate Updates |...
With clinical momentum across its pipeline, atai strengthens its position as a leader in potentially transformative psychedelic mental health treatments
atai life sciences2025 financial results
https://www.financialcontent.com/article/gnwcq-2025-7-1-atai-life-sciences-announces-50-million-private-placement-financing
atai Life Sciences Announces $50 Million Private Placement Financing | FinancialContent
Financing co-led by Ferring Ventures S.A. and Apeiron Investment Ltd. with participation from new and existing healthcare-focused institutional investors,...
atai life sciencesprivate placementannounces50million
https://www.biospace.com/press-releases/atai-life-sciences-announces-pricing-of-public-offering-of-common-shares
atai Life Sciences Announces Pricing of Public Offering of Common Shares - BioSpace
atai life sciencespublic offeringcommon sharesannouncespricing
https://www.financialcontent.com/article/gnwcq-2025-3-17-atai-life-sciences-reports-fourth-quarter-and-full-year-2024-financial-results-and-recent-corporate-highlights
atai Life Sciences Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate...
- Dosed the first patient in the Phase 2 Elumina trial of VLS-01 (buccal film DMT) for patients with treatment-resistant depression; topline data anticipated...
atai life sciences